Discover 1,604 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,604
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Aurora CO, Kansas City MO, Glendale AZ, Tucson AZ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07276581
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Aurora CO, Saint Joseph MO, Gilbert AZ, Springfield MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
for
Eosinophilic Granulomatosis With Polyangiitis (EGPA),
Location: Aurora CO, Cincinnati OH, Highland Hills OH, Toronto
Sponsor: AstraZeneca
Sex: All
Age: 6 - 17
Code: NCT06512883
Phase 3, Recruiting
Cannabis for Palliative Care in Cancer
for
Sleep, Anxiety, Depression, Pain
Location: Aurora CO
Sponsor: University of Colorado, Boulder
Sex: All
Age: 25+
Code: NCT06266611
Phase 2, Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Aurora CO, Rapid City SD, Amarillo TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
for
Hemophilia B
Location: Aurora CO, Phoenix AZ, Dallas TX, Los Angeles CA,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 2+
Code: NCT06379789
Phase 1, Phase 2, Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
for
Hemophilia A
Location: Aurora CO, Minneapolis MN, Iowa City IA, San Antonio TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416604
Phase 3, Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
for
Hemophilia A
Location: Aurora CO, Iowa City IA
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416526
Phase 3, Recruiting
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
for
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy,